Evidence map›Paper›PMID 37722892›Full record

ArticleInternal medicine (Tokyo, Japan)2024

Slowly Progressive ANCA-associated Glomerulonephritis with Strong Mesangial MPO Deposits Following a Diagnosis of Interstitial Lung Disease.

Hitoshi Anzai, Yuki Suzuki, Masaki Ueno, Shinichiro Asakawa, Michito Nagura, Shigeyuki Arai, Osamu Yamazaki, Yoshifuru Tamura, Ryuji Ohashi, Shigeru Shibata and 1 more

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Internal medicine (Tokyo, Japan), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 66% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Hitoshi AnzaiDivision of Nephrology, Department of Internal Medicine, Teikyo University School of Medicine, Japan.
Yuki SuzukiDivision of Respiratory Medicine and Allergology, Department of Internal Medicine, Teikyo University School of Medicine, Japan.
Masaki UenoDivision of Nephrology, Department of Internal Medicine, Teikyo University School of Medicine, Japan.
Shinichiro AsakawaDivision of Nephrology, Department of Internal Medicine, Teikyo University School of Medicine, Japan.
Michito NaguraDivision of Nephrology, Department of Internal Medicine, Teikyo University School of Medicine, Japan.
Shigeyuki AraiDivision of Nephrology, Department of Internal Medicine, Teikyo University School of Medicine, Japan.
Osamu YamazakiDivision of Nephrology, Department of Internal Medicine, Teikyo University School of Medicine, Japan.
Yoshifuru TamuraDivision of Nephrology, Department of Internal Medicine, Teikyo University School of Medicine, Japan.
Ryuji OhashiDepartment of Integrated Diagnostic Pathology, Nippon Medical School, Japan.
Shigeru ShibataDivision of Nephrology, Department of Internal Medicine, Teikyo University School of Medicine, Japan.
Yoshihide FujigakiDivision of Nephrology, Department of Internal Medicine, Teikyo University School of Medicine, Japan.
Teikyo University · JPNippon Medical School · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An elderly woman showed positive conversion of myeloperoxidase (MPO)-antineutrophil cytoplasmic antibodies (ANCAs) following the diagnosis of interstitial lung disease (ILD) and glomerular hematuria and subsequently experienced slowly progressive glomerulonephritis. A kidney biopsy revealed chronic damage and necrotizing crescentic glomerulonephritis with mesangial MPO deposits. After corticosteroid treatment, the patient's urinalysis results and MPO-ANCA titers almost normalized and her renal function stabilized. This case is similar to recently reported cases of slowly progressive ANCA-associated glomerulonephritis. ILD likely triggered the production of MPO-ANCAs, and the accumulation of MPO deposits in the glomeruli may have contributed to the progression of her renal disease.

Indexed as

Antibodies, Antineutrophil CytoplasmicDisease ProgressionGlomerulonephritisLung Diseases, InterstitialPeroxidaseAgedFemaleGlomerular MesangiumHumansAntibodies, Antineutrophil CytoplasmicMPO protein, humanPeroxidaseANAANCA-associated glomerulonephritisidiopathic interstitial pneumoniamyeloperoxidase

Identifiers

PMID37722892
PMCPMC11116029
OpenAlexW4386729893

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.